India to provide second-line HIV drugs free to HIV patients
AIDS (Acquired Immunodeficiency Syndrome or Acquired Immune Deficiency Syndrome, sometimes written Aids) is a human disease characterized by progressive destruction of the body's immune system. It is widely accepted that AIDS results from infection with HIV (Human Immunodeficiency Virus).
India to provide second-line HIV drugs free to HIV patients

HIV :: India to provide second-line HIV drugs free to HIV patients
Indian government committed to providing second-line drugs free of cost to people who develop resistance to the existing treatment for HIV /AIDS.
"As soon as we are able to provide Antiretroviral Therapy (ART) to 100,000 people living with HIV/AIDS in the country, we will introduce second-line drugs," National AIDS Control Organisation Director General Sujatha Rao told reporters in New Delhi.
At the moment, government is providing free ART drugs to 65,000 people living with HIV/AIDS from its 127 treatment sites, which they plan to increase to 250 by 2009.
"It has been a conscious decision to provide first-line treatment to the positive people first, which is affordable and cheaper to provide. The second-line treatment needs more investment and infrastructure," Rao said at the launch of the WHO/UNAIDS/UNICEF joint report on the latest AIDS treatment figures and the health sector's response to the HIV epidemic.
Sujatha Rao said their main focus is now on prevention and care. There are 5.2 million people living with HIV/AIDS in the country.
(
HIV :: India to provide second-line HIV drugs free to HIV patients published at
SpiritIndia on Tuesday, April 17, 2007)
Search more information on
HIVRecently posted related articles on HIV :
- HIV :: A hairpin to fight HIV
- HIV :: Testing delays cause severe AIDS complications, Einstein researchers find
- HIV :: HIV-TB spreads in Africa, undermines control of world's 2 deadliest infectious diseases
- HIV :: HIV patients sicker when seeking care than in the past
- HIV :: UN refugee agency launches HIV/AIDS awareness project in Nepal
- HIV :: A low prevalence of H pylori in HIV-positive patients
- HIV :: HIV linked to increased risk of ESRD in African-Americans
- HIV :: FDA approves new HIV drug raltegravir tablets
- HIV :: Many Africans don't continue HIV AIDS treatment
- HIV :: FDA approves Merck's Isentress, raltegravir tablets for HIV AIDS
»»
Marijuana :: Medical marijuana bill passes senate Health and Human Services Budget Division««
Paget's Disease :: Reclast receives US approval as a treatment for patients with Paget's disease of boneThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com